The conference will gather more than 3000 attendees from 64 countries.
CPhI Russia returns to Moscow from March 28–30, 2017. The event will gather more than 3000 attendees from 64 countries, and 199 exhibitors to network and do business with pharma ingredients, manufacturers, packaging experts, and machining specialists in the region. Attendees will gain in-depth insights from the International Forum, a dedicated matchmaking program, speaker sessions, and other networking opportunities. The program includes detailed analysis on compulsory licensing, drugs labeling, and modern assortment solutions and global trends in the pharmaceutical packaging industry. CPhI Russia offers a matchmaking service that allows companies to meet with relevant partners during the show–it also enables sellers to become buyers as they see new potential suppliers.
According to CPhI, the partnerships and deals struck at CPhI Russia have helped establish Russia at the forefront of pharmerging markets and it is expected to reach a value of $31.2 billion by 2019. This, coupled with a government commitment to invest nearly $5 billion in funding to bring existing manufacturing sites to GMP standards, is driving increased interest in the event. Under the new plan, foreign investment is also encouraged through a fast-track approval process and tax incentives.
“We are seeing a steady growth in three main areas driven by a gentrifying healthcare sector, a rising local population, and government support for domestic manufacturing. Currency variation aside, the pharma market is growing at just under 10% year-on-year and distributers, APIs manufacturers, and machinery providers are seeing high demand across Russia and CIS countries. Traditionally, Russia has been a hard market to enter and that is why CPhI Russia has become so intertwined with the market’s growth,” said Orhan Caglayan, brand director at CPhI Russia in a statement.
Source: CPhI Russia
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.